Abstracts

Reset
Poster Board NumberIDCategoryDocument TitlePresenting
1 1.01 Asthma An assessment of compliance with biologic therapies for severe eosinophilic asthma Ali Al-Mukhaizeem View Abstract
2 1.02 Asthma An audit of acute asthma care in the Emergency Department Jayleigh Lim View Abstract
3 1.03 Asthma Urinary eicosanoids – novel biomarkers in T2-low severe asthma Matthew Chad Eastwood View Abstract
4 1.04 Asthma Can serum total IgE predict the severity of environmental allergies by the size of the Skin prick test wheel?  Fatima Shahbaz View Abstract
5 1.05 Asthma Review Of Use Of Biologics In Children With Severe Asthma- A Single Centre Experience  Mairead Furlong View Abstract
6 1.06 Asthma Patient satisfaction survey Letterkenny University Hospital Infusion (LUH) Unit for patients with severe asthma on Biologic treatments patricia mclaughlin View Abstract
7 1.07 Asthma Adherence to Criteria to Continue Targeted Anti-IL5 Therapy in Severe Refractory Eosinophilic Asthma at 12 Months patricia mclaughlin View Abstract
8 1.08 Asthma Sustainable care: what are the characteristics of people with asthma who successfully switch to low carbon inhaler devices? Laura Piggott View Abstract
9 1.09 Asthma Sustainable care: which people with asthma are offered a lower carbon inhaler device by clinicians and what stops them wanting to switch? Laura Piggott View Abstract
10 1.10 Asthma Accessibility, Usability and Utility of an app-based Digital Asthma Diary Aoife Folliard View Abstract
11 1.11 Asthma An increase in Peak Flow variability reflects T2 inflammation more than ACT or change in FEV1 Ciara Ottewill View Abstract
12 1.12 Asthma Impulse Oscillometry is a useful alternative to spirometry in assessing lung function in people with and without airways disease, particularly in those who struggle to perform spirometry  Sophie Ritchie View Abstract
13 1.13 Asthma Inhaler Usage and Environmental Impact: An Irish perspective on knowledge, attitudes and environmentally friendlier prescription practices.  Tom Farrell View Abstract
14 1.14 Asthma Improving asthma care by implementing elements of the BTS (British Thoracic Society) asthma discharge bundle in the respiratory units in the Royal Hospital, Belfast. Lorraine McKenna View Abstract
15 1.15 Asthma Digital assessment of lung function and ICS/LABA treatment among Irish Severe Asthma Centres – a service evaluation Ahmed Allami View Abstract
16 1.16 Asthma Perception vs Prediction: A Dual Lens on Asthma Exacerbations Cara M Gill View Abstract
17 1.17 Asthma The use of Global Initiative for Asthma (GINA) and Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines in Primary Care. Abi Mani View Abstract
18 1.18 Asthma Impulse oscillometry: Tuning into the subtle frequencies of lung function. Ruaidhri Keane View Abstract
19 1.19 Asthma Comparing the Impact of Biological Treatment in Severe Asthmatics on Markers of Inflammation Laura J Walsh View Abstract
20 1.20 Asthma Evidence of “Neutrophil Swarms” in Endobronchial Biopsies of Severe Asthmatics  Laura J Walsh View Abstract
21 1.21 Asthma Optimising the Formulary in a Tertiary Hospital to Reduce Greenhouse Gas Emissions from Inhalers Deirdre Fitzgerald View Abstract
22 1.22 Asthma Burden of Atopy: Documentation of Atopic Dermatitis Prevalence in a Specialised Asthma Clinic Brian Nolan View Abstract
23 1.23 Asthma An audit of pneumoccal, influenza and covid vaccination among adult asthma patients. Art Kelleher View Abstract
24 1.24 Asthma Evaluation of a Quality Improvement Program for Asthma Care.  Donna Langan View Abstract
25 1.25 Asthma Characterization of the role of human MIF in driving enhanced house dust mite-mediated trained immunity in vitro Molly Dunlop View Abstract
26 1.26 Asthma Acute asthma- optimizing care for patients discharged directly from the Emergency Department Carol Buckley View Abstract
27 1.27 Asthma Enhanced diagnostic assessment in the integrated care setting to guide primary care management of asthma Anne-Marie Sweeney View Abstract
28 1.28 Asthma Multidisciplinary Approach to Improving Patient Care in Patients Presenting with Acute Asthma in the Emergency Department. Lorna Nellany View Abstract
29 1.29 Asthma What is the impact of e-cigarette on asthma exacerbation in the adolescent population Githin Mohan Kallukuzhyil Mohan Das View Abstract
30 1.30 Asthma Real world experience of adrenal insufficiency in patients receiving anti-IL-5 biologic therapy Rory O'Loghlin View Abstract
31 1.31 Asthma Diagnostic accuracy of single and repeated measures of spirometry and type 2 inflammatory markers for asthma in adults already taking inhaled corticosteroids Patrick Kerr View Abstract
32 1.32 Asthma The Asthma Control Test is a non-specific measure of asthma control when used in a modern cohort of symptomatic individuals with clinically apparent uncontrolled asthma. Patrick Kerr View Abstract
33 1.33 Asthma “Don’t Take My Breath Away” – A Tale of Severe Preschool Asthma Genevieve Leon View Abstract
34 1.34 Asthma Green inhaler prescribing is limited by lack of awareness among Irish clinicians Ammar Janjua View Abstract
35 1.35 Asthma Early intervention with asthma education and easy access to care improve outcomes in adult asthma patients.  Aparna Lad View Abstract
36 1.36 Asthma The Impact of Microbiome Supplementation on Managing Asthma Exacerbations in Adults  Ron Goldaphel Alforque View Abstract
37 2.01 Interstitial Lung Disease Routine liver function test monitoring beyond 3 months of antifibrotic initiation can be symptom driven and reduce costs Brian Mullan View Abstract
38 2.02 Interstitial Lung Disease Stakeholder Attitudes to a Potential National Registry for Interstitial Lung Disease Colin Edwards View Abstract
39 2.03 Interstitial Lung Disease To evaluate the role of ATS/ERS/JRS/ALAT high resolution CT-Thorax imaging categories in selecting candidates for transbronchial lung cryobiopsy for undifferentiated interstitial lung disease Sean Landers View Abstract
40 2.04 Interstitial Lung Disease Risk factors for pneumothorax in patients with interstitial lung disease undergoing transbronchial lung cryobiopsy Sean Landers View Abstract
41 2.05 Interstitial Lung Disease Effectiveness of a Tailored Pulmonary Rehabilitation programme for patients with Interstitial Lung Disease. Ann Box View Abstract
42 2.06 Interstitial Lung Disease Induced pluripotent stem cell (iPSC)-derived fibroblasts for the study of Systemic Sclerosis (SSc) Eimear Harkin View Abstract
43 2.07 Interstitial Lung Disease Systemic Sclerosis – Role of the pulmonary microenvironment to drive SSc to SSc-ILD transition Rosa Rodriguez Viera View Abstract
44 2.08 Interstitial Lung Disease Human epididymis protein 4 (HE4) in the pulmonary microenvironment: A window into fibrosis Alexander Reid View Abstract
45 2.09 Interstitial Lung Disease Expanding the Interstitial Lung Disease (ILD) Nursing Service in the Western Health and Social Care Trust: Evaluating the Impact  Siobhán Donnelly View Abstract
46 2.10 Interstitial Lung Disease A 10-year retrospective analysis of transbronchial lung cryobiopsy in the diagnosis of interstitial lung disease. Art Kelleher View Abstract
47 2.11 Interstitial Lung Disease Dapagliflozin in Idiopathic Pulmonary Fibrosis: Investigating its effect on fibrosis and inflammation Bettina Schock View Abstract
48 2.12 Interstitial Lung Disease Aberrant lipid metabolism drives pulmonary fibrosis Marissa O'Callaghan View Abstract
49 2.13 Interstitial Lung Disease Management and follow-up of Birt-Hogg-Dube Syndrome in a rare lung disease clinic Sean Landers View Abstract
50 2.14 Interstitial Lung Disease A retrospective review of clinical characteristics, diagnostic investigations, treatments, and outcomes for patients with Granulomatous Lymphocytic Interstitial Lung Disease at St James Hospital.  Kate Hinchion View Abstract
51 2.15 Interstitial Lung Disease SCREENING FOR CARDIAC SARCOID Amira Mahmood View Abstract
52 2.16 Interstitial Lung Disease Effectiveness of a combined CTD-ILD service:3 years experience at a large tertiary care centre in Ireland Samreen Tariq View Abstract
53 2.17 Interstitial Lung Disease Pulmonary Rehabilitation can be delivered successfully and safely in Interstitial Lung Disease via both in person and virtual classes Grainne Murphy View Abstract
54 2.18 Interstitial Lung Disease Improving ILD patient access to community palliative care through multidisciplinary team working.  Sandra Green View Abstract
55 2.19 Interstitial Lung Disease Interactions between Immunomodulatory Fibroblasts and T Cells regulate lung damage responses in viral and fibrotic lung injury Julie Worrell View Abstract
56 2.20 Interstitial Lung Disease Characteristics of Diffuse Cystic Lung Diseases  in a National Referral Centre Margaret Higgins View Abstract
57 2.21 Interstitial Lung Disease The combined Rheumatology-Respiratory Clinic Cork University Hospital – an audit Peter Leahy View Abstract
58 2.22 Interstitial Lung Disease Real World Data on Antifibrotic Prescribing Practices and impact of ILD MDM on prescribing patterns in SHSCT.  Anne McCord View Abstract
59 2.23 Interstitial Lung Disease Interactions betweeen Immunomodulatory Fibroblasts and T cells regulate Lung Damage responses in Viral and Fibrotic Lung Injury  Julie Worrell View Abstract
60 3.01 Infection Biochemical Classification of Pleural Effusions: Are We Doing It Light? Julia Ulm View Abstract
61 3.02 Infection What is the Impact of the use of Preventative Care Bundles in Non-Ventilator Associated Hospital-Acquired Pneumonia in Hospitalised Adult Patients?  Precious Osoko View Abstract
62 3.03 Infection Anti-Pseudomonas aeruginosa biofilm activity of peptidyl-arginine deiminases  Rory Baird View Abstract
63 3.04 Infection Hospitalised influenza: Patterns pre- & post-pandemic in a district general hospital Arshad Hussain View Abstract
64 3.05 Infection Examining the role of bronchoscopy in the investigation and management of Pneumocystis jirovecii (PJP) infection in HIV patients – a five year retrospective analysis James O'Hanlon View Abstract
65 3.06 Infection A retrospective analysis of five years of culture positive pleural fluid isolates in a tertiary referral centre James O'Hanlon View Abstract
66 3.07 Infection An Audit of Aspergillus Species Isolated from Bronchoalveolar Lavage Specimens Acquired via Flexible Bronchoscopies Performed in a Tertiary Hospital’s Bronchoscopy Unit.   Lorraine Thong View Abstract
67 3.08 Infection The Public Health Impact of Vaccination with the Adjuvanted RSVPreF3 Vaccine in Irish Older Adults Aisling Sheridan View Abstract
68 3.09 Infection Future is Here: Improving CURB65 calculation, documentation and appropriate antibiotic prescribing in Community Acquired Pneumonia through electronic SMART-TOOL.  A two-cycle audit. Aoife McCourt View Abstract
69 3.10 Infection Return of the MAC ! A retrospective review of recurrent Mycobacterium avium complex infection over 16 years in St James Hospital. Kate Hinchion View Abstract
70 3.11 Infection Predictors of Outcomes in Community Acquired Pneumonia Kerri-Marie Heenan View Abstract
71 3.12 Infection Light in the MIST: Evaluating the Efficacy of a Reduced-Dose Intrapleural Thrombolysis Protocol in Pleural Infections: A Comparative Quality Improvement Study. Louay Kila View Abstract
72 3.13 Covid-19 The importance of ARDS patient stratification prior to MSC-based therapy: and the notable impact of MSC-licensing Courteney Tunstead View Abstract
73 3.14 Covid-19 Intensive Care nurses experiences of end of life care during the Covid-19 pandemic: a descriptive qualitative study. Sinead Keating View Abstract
74 3.15 Covid-19 Factors predicting failure to wean from oxygen post discharge following Covid-19 infection. Khalid Gehani View Abstract
75 3.16 Covid-19 Obstructive Sleep Apnea Post-COVID-19, The Role of the Upper Airway Microbiome Christina Campbell View Abstract
76 3.17 Cystic Fibrosis Use of Cardiovascular Risk Scores in Adult Populations with Cystic Fibrosis Jayleigh Lim View Abstract
77 3.18 Cystic Fibrosis A Retrospective Audit of Nephrology Referral Practice Among Inpatients with Cystic Fibrosis.  Suzanne Carter View Abstract
78 3.19 Cystic Fibrosis Determining the impact of co-colonisation on lung function in children with cystic fibrosis. Charles Greally View Abstract
79 3.20 Cystic Fibrosis Prevalence of Dysglycemia in People with Cystic Fibrosis: A Retrospective Analysis St. Vincent’s University Hospital Wail Binalialsharabi View Abstract
80 3.21 Covid-19 Managing Bone Health in Cystic Fibrosis: A Retrospective Review of DXA Scan Practices in a Model 4 Hospital Caitriona Breathnach View Abstract
81 3.22 Covid-19 Invasive Aspergillosis with Covid-19 in Intensive Care – A Retrospective Cohort Study Murali Shyamsundar View Abstract
82 3.23 Cystic Fibrosis Role of Nurse Prescribing in Adult Cystic Fibrosis Service Orla Kerr View Abstract
83 4.01 Physiotherapy A survey of providers’ perceptions of behaviour change interventions for physical activity in people with chronic respiratory disease  Ciara Hanrahan View Abstract
84 4.02 Physiotherapy Interagency community exercise classes for COPD reduce healthcare utilisation  Maeve Sorohan View Abstract
85 4.03 Physiotherapy Introducing Advance Care Planning into Pulmonary Rehabilitation Maeve Sorohan View Abstract
86 4.04 Service Improvement Re-organisation of  Respiratory Outpatient Department in a  District General Hospital Liam Coyle View Abstract
87 4.05 Physiotherapy Levels Of Social Connectedness Amongst Patients Attending Pulmonary Rehabilitation And Maintenance Exercise Groups- A Review Eimear Ward View Abstract
88 4.06 Physiotherapy A community pulmonary rehabilitation programme for patients with high oxygen demands Ciara Feeney View Abstract
89 4.07 Physiotherapy Investigating strength in patients completing pulmonary rehabilitation programme – improved results for patients with sarcopenia Ciara Feeney View Abstract
90 4.08 Physiotherapy The prevalence of sarcopenia in a sub-acute respiratory rehabilitation inpatient unit  Ciara Walsh View Abstract
91 4.09 Physiotherapy Sharing is Caring – Hospital and Community Integrated Pulmonary Rehab Olivia Quinn View Abstract
92 4.10 Service Improvement Dublin North West Respiratory Integrated Care – A Year in Review Johanna O' Callaghan View Abstract
93 4.11 Service Improvement Outcomes following Transfer of the Oxygen Service of Assessment & Review to the Community in the Western Trust, N Ireland Roisin McGarrigle View Abstract
94 4.12 Service Improvement Setting up a virtual ward service at University Hospital Limerick to serve the community catchment area of Mid-West Community Healthcare. Úna O'Connor View Abstract
95 4.13 Physiology Evaluation of Direct GP Access Spirometry in the Galway City Integrated Care Hub  Deirdre McDermott View Abstract
96 4.14 Physiotherapy Patient, process and cost outcomes following the roll-out of a Community Pulmonary Rehabilitation Programme in HSE Mid-West region: A service and economic evaluation  Sarah Cunneen View Abstract
97 4.15 Physiotherapy Pulmonary Rehabilitation outcomes analysis – Does class location or referral source impact patient outcomes? Sarah Cunneen View Abstract
98 4.16 Service Improvement Oxygen prescription compliance in a large Irish hospital – a quality improvement project William Griffin View Abstract
99 4.17 Service Improvement Improving Asthma and COPD services at Sligo University Hospital: Respiratory ANP Clinic Lorna Nellany View Abstract
100 4.18 Physiotherapy Start and Finish: A 6 month review of uptake and completion barriers to Pulmonary Rehabilitation in Respiratory Integrated Care Dublin North Central and Dublin North West Clodagh O'Meara View Abstract
101 4.19 Physiotherapy Share your screen: A Virtual Pulmonary Rehabilitation Collaboration in CHO9 Clodagh O'Meara View Abstract
102 4.20 Physiotherapy Therapeutic Harmonica Programme: Preliminary Findings Brenda Deering View Abstract
103 4.21 Physiotherapy Physiotherapy Role in the Pre Lung Transplant Clinic at the Irish National Heart and Lung Transplant Centre  Patricia Costello View Abstract
104 4.22 Physiotherapy A Review of Prescribed Unsupervised Walking Exercise Programmes in Pulmonary Rehabilitation; a Service Development  Amy Fay View Abstract